Skip to main content
OpenTrials
Completed

NCT Number: NCT02401932

Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow

Comparison of malignant and non-malignant disorders associated bone marrow hemophagocytosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center

Seoul, 135-710, South Korea

About this study

This is a retrospective study comparing malignant and non-malignant disorders associated bone marrow hemophagocytosis. The medical record of patients who had documented evidences of hemophagocytosis in bone marrow are reviewed. The clinical and biological characteristics are compared according to the underlying disorders of hemophagocytosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who had evidence of hemophagocytic histiocytosis in bone marrow aspiration and biopsy

Exclusion criteria

  • patients who did not evidence of hemophagocytic histiocytosis in bone marrow aspiration and biopsy

Treatment and study plan

Hemophagocytosis

Other

Best supportive care and immunosuppressive treatments

Primary outcomes

  1. Overall survival

    Time frame: 12 Months

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Official study title

Comparison of Malignant and Non-malignant Disorders Associated Bone Marrow Hemophagocytosis: A Single Center Experience

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Mar 30, 2015
Registry last updated
Nov 10, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.